Park YH - Search Results

1

Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer.

Paik KH, Park YH, Ryoo BY, Yang SH, Lee JC, Kim CH, Ki SS, Kim JM, Park MJ, Ahn HJ, Choi W, Chung JH. Paik KH, et al. Among authors: park yh, park mj. J Korean Med Sci. 2006 Feb;21(1):35-9. doi: 10.3346/jkms.2006.21.1.35. J Korean Med Sci. 2006. PMID: 16479062 Free PMC article.

2

Primary malignant lymphoma of the breast: clinicopathological study of nine cases.

Park YH, Kim SH, Choi SJ, Ryoo BY, Kang YK, Lee SS. Park YH, et al. Leuk Lymphoma. 2004 Feb;45(2):327-30. doi: 10.1080/10428190310001597892. Leuk Lymphoma. 2004. PMID: 15101719

3

Gemcitabine and vinorelbine as second-line therapy for non-small cell lung cancer after treatment with paclitaxel plus platinum.

Park YH, Lee JC, Kim CH, Ryoo BY, Kim HT. Park YH, et al. Jpn J Clin Oncol. 2004 May;34(5):245-9. doi: 10.1093/jjco/hyh043. Jpn J Clin Oncol. 2004. PMID: 15231858 Clinical Trial.

4

A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site.

Park YH, Ryoo BY, Choi SJ, Yang SH, Kim HT. Park YH, et al. Jpn J Clin Oncol. 2004 Nov;34(11):681-5. doi: 10.1093/jjco/hyh124. Jpn J Clin Oncol. 2004. PMID: 15613558 Review.

5

PET imaging with F-18 fluorodeoxyglucose for primary lymphoma of bone.

Park YH, Choi SJ, Ryoo BY, Kim HT. Park YH, et al. Clin Nucl Med. 2005 Feb;30(2):131-4. doi: 10.1097/00003072-200502000-00020. Clin Nucl Med. 2005. PMID: 15647689 No abstract available.

6

Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.

Lee J, Park YH, Kim WS, Lee SS, Ryoo BY, Yang SH, Park KW, Kang JH, Park JO, Lee SH, Kim K, Jung CW, Park YS, Im YH, Kang WK, Lee MH, Ko YH, Ahn YC, Park K. Lee J, et al. Among authors: park yh, park kw, park ys, park jo, park k. Eur J Cancer. 2005 Jul;41(10):1402-8. doi: 10.1016/j.ejca.2005.03.010. Eur J Cancer. 2005. PMID: 15963893

7

Secondary hematological malignancies after breast cancer chemotherapy.

Park MJ, Park YH, Ahn HJ, Choi W, Paik KH, Kim JM, Chang YH, Ryoo BY, Yang SH. Park MJ, et al. Among authors: park yh. Leuk Lymphoma. 2005 Aug;46(8):1183-8. doi: 10.1080/10428190500125705. Leuk Lymphoma. 2005. PMID: 16085560

8

A case of uterine cervical cancer presenting with granulocytosis.

Ahn HJ, Park YH, Chang YH, Park SH, Kim MS, Ryoo BY, Yang SH. Ahn HJ, et al. Among authors: park yh, park sh. Korean J Intern Med. 2005 Sep;20(3):247-50. doi: 10.3904/kjim.2005.20.3.247. Korean J Intern Med. 2005. PMID: 16295785 Free PMC article.

9

High-dose therapy and autologous stem cell transplantation in Korean patients with aggressive T/NK-cell lymphoma.

Bang SM, Kim YK, Park YH, Sohn SK, Lee JJ, Cho EK, Ryoo BY, Chung IJ, Yoon SS, Kim HJ, Lee JH, Yoon HJ, Park S. Bang SM, et al. Among authors: park yh, park s. Leuk Lymphoma. 2005 Nov;46(11):1599-1604. doi: 10.1080/10428190500215191. Leuk Lymphoma. 2005. PMID: 16334486

10

Gastric Burkitt lymphoma is a distinct subtype that has superior outcomes to other types of Burkitt lymphoma/leukemia.

Park YH, Kim WS, Kang HJ, Na II, Ryoo BY, Yang SH, Lee SS, Uhm JE, Kim K, Jung CW, Park K, Ko YH. Park YH, et al. Among authors: park k. Ann Hematol. 2006 May;85(5):285-90. doi: 10.1007/s00277-005-0050-8. Epub 2006 Mar 4. Ann Hematol. 2006. PMID: 16518604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,097 results

Search Page